You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 1, January 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  NEWS AND VIEWS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Forty Years of Lithium Treatment

Mogens Schou, MD, DrMed, DrHCMult
From the Psychiatric Hospital, Risskov, Denmark.

Arch Gen Psychiatry. 1997;54(1):9-13.


Abstract

This review is based on a lecture in which I was requested to present my personal experiences and views. Since its introduction into psychiatry more than 40 years ago, lithium treatment has in most countries gained wide acceptance in the prophylaxis of unipolar and bipolar affective disorders. At one time it was feared that lithium treatment might lead to a decrease in the glomerular filtration rate, but systematically collected data indicate that even long-term treatment does not induce renal insufficiency. During treatment, regular laboratory monitoring of serum lithium and creatinine concentrations is recommended. Recent studies suggest that long-term lithium treatment does not raise the mortality of manic-depressive patients and indeed may have a mortality-lowering and antisuicidal effect. Despite the availability of alternative therapies, lithium remains the treatment of choice for the prophylaxis of recurrent manic-depressive illness.




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transcriptional, Proteomic, and Metabolic Responses to Lithium in Galactose-grown Yeast Cells
Bro et al.
J. Biol. Chem. 2003;278:32141-32149.
ABSTRACT | FULL TEXT  

Two-Year Prospective Follow-Up of Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype
Geller et al.
Am. J. Psychiatry 2002;159:927-933.
ABSTRACT | FULL TEXT  

Use of Antidepressants to Treat Depression in Bipolar Disorder
El-Mallakh and Karippot
Psychiatr. Serv. 2002;53:580-584.
ABSTRACT | FULL TEXT  

Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression
Nemeroff et al.
Am. J. Psychiatry 2001;158:906-912.
ABSTRACT | FULL TEXT  

Lithium: The Oldest Specific Psychotropic Medication
JWatch Psychiatry 2000;2000:6-6.
FULL TEXT  

A Review of Bipolar Disorder Among Adults
Hilty et al.
Psychiatr. Serv. 1999;50:201-213.
ABSTRACT | FULL TEXT  

Standards of laboratory practice: antidepressant drug monitoring
Linder and Keck
Clin. Chem. 1998;44:1073-1084.
ABSTRACT | FULL TEXT  

Forty Years of Lithium Treatment
Moncrieff et al.
Arch Gen Psychiatry 1998;55:92-93.
FULL TEXT  

Forty Years of Lithium Treatment
Kupfer and Frank
Arch Gen Psychiatry 1997;54:14-15.
ABSTRACT  

Current Therapeutic Profile of Lithium
Gershon and Soares
Arch Gen Psychiatry 1997;54:16-20.
ABSTRACT  

Unanswered Questions, Unknown Future for One of Our Oldest Medications
Gitlin and Altshuler
Arch Gen Psychiatry 1997;54:21-23.
ABSTRACT  

Phosphoglucomutase Is an in Vivo Lithium Target in Yeast
Masuda et al.
J. Biol. Chem. 2001;276:37794-37801.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.